DeepIntent

DeepIntent

Healthcare DSP for targeted ads

About DeepIntent

Simplify's Rating
Why DeepIntent is rated
B+
Rated B on Competitive Edge
Rated A on Growth Potential
Rated B on Differentiation

Industries

Data & Analytics

Enterprise Software

Cybersecurity

Healthcare

Company Size

201-500

Company Stage

Debt Financing

Total Funding

$677M

Headquarters

New York City, New York

Founded

2016

Overview

DeepIntent operates a demand-side platform tailored to healthcare advertising. It helps healthcare marketers plan, activate, and measure digital ad campaigns across channels to reach both patients and healthcare professionals. The platform uses a proprietary ID graph and an HCP Planner to build precise audiences from trusted data, ensuring ads reach relevant viewers while maintaining privacy and data security in a single, secure environment. This specialization sets DeepIntent apart from general ad tech providers by focusing on healthcare privacy compliance, targeted HCP and patient audiences, and a premium marketplace of brand-safe inventory. The company's goal is to enable effective, privacy-compliant digital campaigns for healthcare clients and demonstrate clear campaign impact through robust measurement and analytics.

Simplify Jobs

Simplify's Take

What believers are saying

  • Vitruvian Partners' $637M investment accelerates AI integration via DeepIntent Cortex.
  • $40MM SLR credit facility extends to September 2030, boosting financial flexibility.
  • HealthFirst expansion with iHeartMedia audio and FAST solution scales premium inventory.

What critics are saying

  • Google Privacy Sandbox excludes healthcare signals, blocking Chrome's 65% share immediately.
  • AdTheorent captures 15-20% clients with clean rooms in 12-18 months.
  • Amazon DSP diverts 25% premium spend using AWS HealthLake in 9-15 months.

What makes DeepIntent unique

  • MarketMatch platform unifies advertisers, publishers, and data providers in privacy-safe healthcare marketplace.
  • Proprietary ID graph matches clinical data with digital IDs for real-time targeting.
  • Founded by Memorial Sloan Kettering data scientists, serving 20+ pharma companies since 2016.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$677M

Above

Industry Average

Funded Over

3 Rounds

Debt funding comparison data is currently unavailable. We're working to provide this information soon!
Debt Funding Comparison
Coming Soon

Benefits

Remote Work Options

Performance Bonus

Company News

ABL Advisor
Oct 30th, 2025
SLR Digital Finance Provides $40MM Credit Facility to DeepIntent - News | ABL Advisor

SLR Digital Finance (“SLRDF”) provided a $40 million senior secured revolving ABL credit facility to DeepIntent, a leading healthcare advertising demand-side platform (DSP). The facility includes improved terms and an extended maturity through September 2030, providing continued flexibility and support for the Company following a recent investment...

Stock Titan
Sep 30th, 2025
DeepIntent Expands HealthFirst(TM) Media Suite with Audio Package, Connecting Healthcare Brands to Trusted Streaming Publishers

By partnering with DeepIntent, which has specialized compliance infrastructure for healthcare advertising, iHeartMedia can potentially reduce barriers to entry in this lucrative vertical while leveraging its extensive audio reach.

DeepIntent
Sep 10th, 2025
DeepIntent Secures $637M Investment from Vitruvian Partners

Funding will accelerate DeepIntent’s next phase of growth, product development, and industry leadership – empowering clients with smarter marketing solutions

Adweek
Sep 9th, 2025
DeepIntent Secures $637M for AI Development

DeepIntent, a healthcare adtech firm, secured a $637 million investment from Vitruvian Partners, which now holds a majority share. The funding will be used to integrate generative AI tools into DeepIntent's platform. The company will continue to operate independently under CEO Chris Paquette, with a reconstituted board of directors. Vitruvian Partners expressed confidence in DeepIntent's role in personalized healthcare and data-driven advertising.

Adweek
Sep 9th, 2025
Healthcare Adtech Firm DeepIntent Clinches $637M in Funding for AI Product Development

DeepIntent, a demand-side platform that helps healthcare and pharma brands including AstraZeneca, Bayer, Gilead, and Johnson & Johnson buy ad space, announced Tuesday that it's secured a $637 million investment from private equity firm Vitruvian Partners.

Recently Posted Jobs

Sign up to get curated job recommendations

DeepIntent is Hiring for 9 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →